These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33812581)

  • 21. Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress.
    Lucchi L; Bergamini S; Botti B; Rapanà R; Ciuffreda A; Ruggiero P; Ballestri M; Tomasi A; Albertazzi A
    Artif Organs; 2000 Jan; 24(1):1-6. PubMed ID: 10677150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes.
    Piroddi M; Pilolli F; Aritomi M; Galli F
    Am J Nephrol; 2012; 35(6):559-72. PubMed ID: 22677717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of different dialysis membranes on erythrocyte antioxidant enzyme levels and scavenger systems related to free hemoglobin in serum of hemodialysis patients.
    Salamunić I; Juretić D; Ljutić D
    Clin Chem Lab Med; 2003 Jul; 41(7):904-7. PubMed ID: 12940516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes.
    Schönermarck U; Dengler C; Ebeling F; Heydenreich M; Hillebrand GF; Samtleben W
    Clin Nephrol; 2006 Nov; 66(5):357-63. PubMed ID: 17140165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vorapaxar-modified polysulfone membrane with high hemocompatibility inhibits thrombosis.
    Liu W; Fu X; Liu YF; Su T; Peng J
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111508. PubMed ID: 33255066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients.
    Bargnoux AS; Cristol JP; Jaussent I; Chalabi L; Bories P; Dion JJ; Henri P; Delage M; Dupuy AM; Badiou S; Canaud B; Morena M
    J Nephrol; 2013; 26(3):556-63. PubMed ID: 22956433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrophilic, semipermeable membranes fabricated with poly(ethylene oxide)-polysulfone block copolymer.
    Hancock LF; Fagan SM; Ziolo MS
    Biomaterials; 2000 Apr; 21(7):725-33. PubMed ID: 10711969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane.
    Sirolli V; Ballone E; Di Stante S; Amoroso L; Bonomini M
    Int J Artif Organs; 2002 Jun; 25(6):529-37. PubMed ID: 12117292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced hydrophilicity and anticoagulation of polysulfone materials modified via dihydroxypropyl, sulfonic groups and chitosan.
    Wang C; Lin B; Qiu Y
    Colloids Surf B Biointerfaces; 2022 Feb; 210():112243. PubMed ID: 34861540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemically modified polysulfone hollow fibers with vinylpyrrolidone having improved blood compatibility.
    Higuchi A; Shirano K; Harashima M; Yoon BO; Hara M; Hattori M; Imamura K
    Biomaterials; 2002 Jul; 23(13):2659-66. PubMed ID: 12059015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood.
    Bosch-Panadero E; Mas S; Sanchez-Ospina D; Camarero V; Pérez-Gómez MV; Saez-Calero I; Abaigar P; Ortiz A; Egido J; González-Parra E
    J Am Soc Nephrol; 2016 May; 27(5):1566-74. PubMed ID: 26432902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodialysis with cuprophane or polysulfone: effects on uremic polyneuropathy.
    Robles NR; Murga L; Galvan S; Esparrago JF; Sanchez-Casado E
    Am J Kidney Dis; 1993 Mar; 21(3):282-7. PubMed ID: 8383423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dialysis treatment, in vitro, and anticoagulation activity of polysulfone-polyacrylamide based-blend membranes: an experimental study.
    Zaman SU; Mehdi MS
    J Biomater Sci Polym Ed; 2024 Sep; ():1-22. PubMed ID: 39228062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of biocompatibility in polysulfone dialysis membranes with different sterilization.
    Togo K; Yamamoto M; Ono T; Imai M; Akiyama K; Ebine K; Yamashita AC
    Hemodial Int; 2018 Oct; 22(S2):S10-S14. PubMed ID: 30411467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of polysulfone with phospholipid polymer for improvement of the blood compatibility. Part 2. Protein adsorption and platelet adhesion.
    Ishihara K; Fukumoto K; Iwasaki Y; Nakabayashi N
    Biomaterials; 1999 Sep; 20(17):1553-9. PubMed ID: 10482409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polysulfone hemodiafiltration membranes with enhanced anti-fouling and hemocompatibility modified by poly(vinyl pyrrolidone) via in situ cross-linked polymerization.
    Zhu L; Song H; Wang J; Xue L
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():159-166. PubMed ID: 28254281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.